Challenges and solutions: The present and future of cell therapies for T1D
Breakthrough T1D is funding research that supports manufactured islet cell source, survival, and protection and is also driving initiatives to…
How to support someone you love who lives with type 1 diabetes (without pressure)
Simple ways to support someone living with T1D without pressure or making things awkward.
Medical Affairs: Closing the gap between access and adoption
Breakthrough T1D's new Medical Affairs unit will address the numerous challenges contributing to the slow adoption of groundbreaking T1D therapies.
Nobel laureates, women, and diabetes discoveries
Gerty Cori, Ph.D., Dorothy Crowfoot Hodgkin, FRS, and Rosalyn Yalow, Ph.D., won the Nobel Prize for diabetes discoveries.
What is autoimmune disease?
Learn the basics about autoimmune disease, including prevalence in the U.S., possible causes, and why they are often called "invisible."
Shining the spotlight on Breakthrough T1D scientist Dr. Cassandra Bazile
Dr. Cassandra Bazile is a scientist at Breakthrough T1D who champions community, mentorship, and inclusion in STEM.
T1D takes center stage in Kansas City
The Coterie Theatre recently presented the world premiere of Just Ask!, a new musical based on The New York Times…
Letter from Aaron J. Kowalski, PhD, CEO of Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes research and advocacy organization, to Robert F. Kennedy Jr., United States Secretary of Health and Human Services (HHS)
Dear Secretary Kennedy, Congratulations on your confirmation as United States Secretary of Health and Human Services. On behalf of the…
Improving lives through clinical trials
Marjorie Lazarre has seen the life-changing outcomes of T1D research and is confident clinical trials are the path to cures.
A behind-the-scenes look at DIAGNODE-3: Phase 3 clinical trials of Diamyd® for T1D
DIAGNODE-3 is a phase 3 clinical trial of the disease-modifying therapy Diamyd® that aims to preserve insulin-producing beta cells.
